Categories: Company News

Ranbaxy stops shipments from Toansa, Dewas plants

New Delhi February 26, 2014:- Ranbaxy Laboratories has halted all shipments of pharmaceutical ingredients from its Toansa and Dewas plants.

In a statement to the BSE on Tuesday, the company said it is examining processes and controls at all its active pharmaceutical ingredients (API) manufacturing and quality units. The decision comes in the backdrop of the recent US ban on products manufactured at these units. The move is likely to hit supplies to Ranbaxy’s other key markets, including Europe. Both plants — Toansa in Punjab, and Dewas in Madhya Pradesh — along with two more plants, Paonta Sahib in Himachal Pradesh and Mohali in Punjab, have been banned from exporting pharmaceutical ingredients as well as finished goods to the US.

While announcing its results for the fourth quarter recently, Ranbaxy had said the US ban on the Toansa plant had hit the company’s sales by 10-15 per cent.

“Since, the company has voluntarily withdrawn its production; we believe that it would have made alternative arrangements for production,” said Sarabjit Kour Nangra, Vice-President (Research), Pharma, Angel Broking.

Another industry expert said Ranbaxy would most probably have to procure drug ingredients from other companies in order to continue manufacturing finished medicines and this would push up costs for the company, hitting its margins.

The drug major said this voluntary action has been taken as a “precautionary measure” and shipments will be resumed after all processes have been assessed.

“A committee of the Board has been constituted … to help and assure good governance to all Ranbaxy stakeholders,” the company said in a statement.

The pharma major’s shares rose 0.99 per cent on the BSE to close at ₹367.05 apiece on Tuesday.- Business Line

The Pharma Times News Bureau

Recent Posts

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

20 hours ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

20 hours ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

2 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

2 days ago

Annual eye screening crucial for diabetic patients to protect eyesight: Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital, Bengaluru, is providing free consultations for diabetic patients aged 50 and…

4 days ago

7 Signs You Are Suffering From Protein Deficiency

By Ms. Archana S, Senior Nutritionist, Aster Whitefield Hospital, Bengaluru As an essential nutrient, protein…

4 days ago